465-479
REVIEW
Update on subarachnoid haemorrhage
J. M. Ferro, P. Canhão and R. Peralta
480-487
ORIGINAL COMMUNICATION
Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b
C. Polman, L. Kappos, M. S. Freedman, G. Edan and H.-P. Hartung, et al.
488-494
ORIGINAL COMMUNICATION
Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration
Albert Lladó, Raquel Sánchez-Valle, Maria Jesús Rey, Mario Ezquerra and Eduardo Tolosa, et al.
495-501
ORIGINAL COMMUNICATION
“Pseudodominant inheritance” of ataxia with ocular apraxia type 2 (AOA2)
L. Schöls, L. Arning, R. Schüle, J. T. Epplen and D. Timmann
502-509
ORIGINAL COMMUNICATION
Severity of explicit memory impairment due to Alzheimer’s disease improves effectiveness of implicit learning
A. Klimkowicz-Mrowiec, A. Slowik, L. Krzywoszanski, R. Herzog-Krzywoszanska and A. Szczudlik
510-513
ORIGINAL COMMUNICATION
Mycophenolate mofetil
for ocular myasthenia
J. W. Chan
514-519
ORIGINAL COMMUNICATION
Thrombomodulin gene polymorphisms in brain infarction and mortality after stroke
J.-M. Olivot, J. Labreuche, T. De Broucker, O. Poirier and F. Cambien, et al.
520-525
ORIGINAL COMMUNICATION
Cerebral blood flow abnormality in patients with idiopathic generalized epilepsy
E. Y. Joo, W. S. Tae and S. B. Hong
526-531
ORIGINAL COMMUNICATION
Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy
C. Kraemer, S. Evers, T. Nolting, G. Arendt and I. W. Husstedt
532-538
ORIGINAL COMMUNICATION
Signs of impaired selective attention in patients with amyotrophic lateral sclerosis
E. H. Pinkhardt, R. Jürgens, W. Becker, M. Mölle and J. Born, et al.
539-544
ORIGINAL COMMUNICATION
Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration
D. Galimberti, E. Venturelli, C. Fenoglio, I. Guidi and C. Villa, et al.
545-550
ORIGINAL COMMUNICATION
Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis
J. Costa, M. L. Rocha, J. Ferreira, T. Evangelista and M. Coelho, et al.
551-560
ORIGINAL COMMUNICATION
Radiosurgery of brain arteriovenous malformations in children
D. R. Buis, C. M. F. Dirven, F. J. Lagerwaard, E. S. Mandl and G. J. Lycklama á Nijeholt, et al.
561-566
ORIGINAL COMMUNICATION
Cortical thickness abnormality in juvenile myoclonic epilepsy
W. S. Tae, S. H. Kim, E. Y. Joo, S. J. Han and I. Y. Kim, et al.
567-574
ORIGINAL COMMUNICATION
Volumetric MRI and cognitive measures in Alzheimer disease
Comparison of markers of progression
B. H. Ridha, V. M. Anderson, J. Barnes, R. G. Boyes and S. L. Price, et al.
575-580
ORIGINAL COMMUNICATION
18F-FDG PET in neurodegenerative Langerhans cell histiocytosis
Results and potential interest for an early diagnosis of the disease
M.-J. Ribeiro, A. Idbaih, C. Thomas, P. Remy and N. Martin-Duverneuil, et al.
581-586
ORIGINAL COMMUNICATION
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis
M. Calabrese, N. De Stefano, M. Atzori, V. Bernardi and I. Mattisi, et al.
587-591
ORIGINAL COMMUNICATION
Thalidomide causes sinus bradycardia in ALS
T. Meyer, A. Maier, N. Borisow, J. S. Dullinger and G. Splettstößer, et al.
592-593
LETTER TO THE EDITORS
Increased MS relapse rate during assisted reproduction technique
K. Hellwig, C. Beste, N. Brune, A. Haghikia and T. Müller, et al.
594-596
LETTER TO THE EDITORS
Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma
D. Van Diest, H. De Raeve, J. Claes, P. M. Parizel and D. De Ridder, et al.
597-598
LETTER TO THE EDITORS
Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man
D. M. Campbell, S. Bruins, H. Vogel, L. M. Shuer and C. A. C. Wijman
599-600
LETTER TO THE EDITORS
Cerebral ultrasound perfusion imaging in a migraine attack with prolonged aura
W. Marouf, A. Hetzel, M. Reinhard and W.-D. Niesen
601-603
LETTER TO THE EDITORS
Transverse venous sinus stenosis and intracranial hypertension: evidence for which comes first
R. Simister, J. V. Bowler, P. L. Wilson, B. Unwin and D. Kidd
604-606
LETTER TO THE EDITORS
Late onset familial Alzheimer's disease: novel presenilin 2 mutation and PS1 E318G polymorphism
L. Bernardi, C. Tomaino, M. Anfossi, M. Gallo and S. Geracitano, et al.
607-608
LETTER TO THE EDITORS
Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome
U.-M. Sheerin, J. Barreto, M. M. Brown, S. Brew and N. A. Losseff
609-611
LETTER TO THE EDITORS
Unique PABPN1 gene mutation in a large Bulgarian family with OPMD
V. Mihaylova, T. Müller, I. Petrova, I. Tournev and S. Cherninkova, et al.
612-613
LETTER TO THE EDITORS
Spinocerebellar ataxia type 4 and 16q22.1-linked Japanese ataxia are not allelic
Y. Hellenbroich, V. Bernard and C. Zühlke
614-615
PIONEERS IN NEUROLOGY
Josef Gerstmann (1887–1969)
Lazaros C. Triarhou
616-618
JOURNAL CLUB
Parkinson's disease: PET studies, neural stem cells and an adenosine receptor antagonist
Michael Strupp
619-622
COMMUNICATIONS
Communications of the European Neurological Society